$PODD
INSULET CORP Stock $podd

$podd Overview Financials Valuation SEC Filings Company Website

2018 Q2 Form 10-Q Financial Statement

#000114519718000011 Filed on August 02, 2018

Income Statement

Concept	2018 Q2	2017 Q2
Revenue	$124.2M	$109.8M
YoY Change	13.16%	25.68%
Cost Of Revenue	$42.19M	$45.12M
YoY Change	-6.49%	22.36%
Gross Profit	$82.10M	$64.64M
YoY Change	27.01%	28.11%
Gross Profit Margin	66.1%	58.89%
Selling, General & Admin	$58.95M	$49.97M
YoY Change	17.97%	28.81%
% of Gross Profit	71.8%	77.3%
Research & Development	$18.80M	$18.03M
YoY Change	4.28%	39.19%
% of Gross Profit	22.9%	27.89%
Depreciation & Amortization	$3.610M	$3.390M
YoY Change	6.49%	-1.17%
% of Gross Profit	4.4%	5.24%
Operating Expenses	$77.75M	$68.00M
YoY Change	14.34%	31.41%
Operating Profit	$4.325M	-$3.358M
YoY Change	-228.8%	160.71%
Interest Expense	$7.290M	-$4.300M
YoY Change	-269.53%	43.33%
% of Operating Profit	168.55%
Other Income/Expense, Net	-$5.604M	-$4.308M
YoY Change	30.08%	43.7%
Pretax Income	-$1.279M	-$7.666M
YoY Change	-83.32%	78.86%
Income Tax	$412.0K	$101.0K
% Of Pretax Income
Net Earnings	-$1.700M	-$7.767M
YoY Change	-78.11%	85.02%
Net Earnings / Revenue	-1.37%	-7.08%
Basic Earnings Per Share	-$0.03
Diluted Earnings Per Share	-$0.03	-$134.5K
COMMON SHARES
Basic Shares Outstanding	58.83M shares	57.92M shares
Diluted Shares Outstanding	58.83M shares

Balance Sheet

Concept	2018 Q2	2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$299.8M	$258.6M
YoY Change	15.93%	132.35%
Cash & Equivalents	$136.2M	$73.49M
Short-Term Investments	$163.5M	$185.1M
Other Short-Term Assets	$17.60M	$8.400M
YoY Change	109.52%	23.53%
Inventory	$40.81M	$33.96M
Prepaid Expenses	$11.01M
Receivables	$49.68M	$37.75M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$421.8M	$338.7M
YoY Change	24.52%	86.85%
LONG-TERM ASSETS
Property, Plant & Equipment	$197.6M	$75.88M
YoY Change	160.37%	84.48%
Goodwill	$39.73M	$39.76M
YoY Change	-0.07%	-0.01%
Intangibles
YoY Change
Long-Term Investments	$156.1M
YoY Change
Other Assets	$2.486M	$1.559M
YoY Change	59.46%	1671.59%
Total Long-Term Assets	$417.1M	$120.6M
YoY Change	245.88%	47.49%
TOTAL ASSETS
Total Short-Term Assets	$421.8M	$338.7M
Total Long-Term Assets	$417.1M	$120.6M
Total Assets	$838.9M	$459.3M
YoY Change	82.63%	74.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$25.19M	$12.24M
YoY Change	105.76%	-43.33%
Accrued Expenses	$48.58M	$34.65M
YoY Change	40.21%	15.73%
Deferred Revenue	$2.338M
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$76.11M	$48.02M
YoY Change	58.5%	-12.98%
LONG-TERM LIABILITIES
Long-Term Debt	$577.1M	$340.8M
YoY Change	69.32%	94.0%
Other Long-Term Liabilities	$6.480M	$5.748M
YoY Change	12.73%	21.52%
Total Long-Term Liabilities	$583.6M	$346.6M
YoY Change	68.39%	92.1%
TOTAL LIABILITIES
Total Short-Term Liabilities	$76.11M	$48.02M
Total Long-Term Liabilities	$583.6M	$346.6M
Total Liabilities	$659.7M	$394.6M
YoY Change	67.18%	67.49%
SHAREHOLDERS EQUITY
Retained Earnings	-$695.2M	-$698.2M
YoY Change	-0.43%	4.48%
Common Stock	$59.00K	$58.00K
YoY Change	1.72%	1.75%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$179.1M	$64.73M
YoY Change
Total Liabilities & Shareholders Equity	$838.9M	$459.3M
YoY Change	82.63%	74.62%

Cashflow Statement

Concept	2018 Q2	2017 Q2
OPERATING ACTIVITIES
Net Income	-$1.700M	-$7.767M
YoY Change	-78.11%	85.02%
Depreciation, Depletion And Amortization	$3.610M	$3.390M
YoY Change	6.49%	-1.17%
Cash From Operating Activities	-$6.130M	$17.97M
YoY Change	-134.11%	388.32%
INVESTING ACTIVITIES
Capital Expenditures	-$54.57M	-$13.39M
YoY Change	307.54%	386.91%
Acquisitions
YoY Change
Other Investing Activities	-$6.560M	-$8.590M
YoY Change	-23.63%	-75.09%
Cash From Investing Activities	-$61.11M	-$21.98M
YoY Change	178.03%	-40.98%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	700.0K	1.260M
YoY Change	-44.44%	-152.28%
NET CHANGE
Cash From Operating Activities	-6.130M	17.97M
Cash From Investing Activities	-61.11M	-21.98M
Cash From Financing Activities	700.0K	1.260M
Net Change In Cash	-66.54M	-2.750M
YoY Change	2319.64%	-92.35%
FREE CASH FLOW
Cash From Operating Activities	-$6.130M	$17.97M
Capital Expenditures	-$54.57M	-$13.39M
Free Cash Flow	$48.44M	$31.36M
YoY Change	54.46%	387.71%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-661000	USD
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
	dei	Document Period End Date DocumentPeriodEndDate	2018-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001145197
CY2018Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	58997012	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	INSULET CORPORATION
	dei	Trading Symbol TradingSymbol	PODD
CY2018Q2	podd	Capitalized Contract Cost Current CapitalizedContractCostCurrent	6600000	USD
CY2018Q2	podd	Capitalized Contract Cost Noncurrent CapitalizedContractCostNoncurrent	15500000	USD
CY2017Q2	podd	Debt Instrument Stated Coupon Rate Interest Expense DebtInstrumentStatedCouponRateInterestExpense	1413000	USD
	podd	Debt Instrument Stated Coupon Rate Interest Expense DebtInstrumentStatedCouponRateInterestExpense	2827000	USD
CY2018Q2	podd	Debt Instrument Stated Coupon Rate Interest Expense DebtInstrumentStatedCouponRateInterestExpense	2462000	USD
	podd	Debt Instrument Stated Coupon Rate Interest Expense DebtInstrumentStatedCouponRateInterestExpense	4942000	USD
CY2018Q2	podd	Finite Lived Intangible Assets Amortization Expense Thereafter FiniteLivedIntangibleAssetsAmortizationExpenseThereafter	170000	USD
CY2018Q2	podd	Finited Lived Intangible Assets Excluding Software In Process Of Development Net FinitedLivedIntangibleAssetsExcludingSoftwareInProcessOfDevelopmentNet	5747000	USD
	podd	Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities	-7408000	USD
	podd	Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities	-17873000	USD
	podd	Increase Decrease In Accounts Receivable And Unbilled Revenue IncreaseDecreaseInAccountsReceivableAndUnbilledRevenue	9630000	USD
	podd	Increase Decrease In Accounts Receivable And Unbilled Revenue IncreaseDecreaseInAccountsReceivableAndUnbilledRevenue	7217000	USD
CY2017Q2	podd	Interestand Other Expense Total InterestandOtherExpenseTotal	5485000	USD
	podd	Interestand Other Expense Total InterestandOtherExpenseTotal	10894000	USD
CY2018Q2	podd	Interestand Other Expense Total InterestandOtherExpenseTotal	9726000	USD
	podd	Interestand Other Expense Total InterestandOtherExpenseTotal	19369000	USD
CY2018Q2	podd	Number Of Financial Institution NumberOfFinancialInstitution	1	location
CY2017	podd	Percentage Of Accounts Payable Accrued Expensesand Other Current Liabilities PercentageOfAccountsPayableAccruedExpensesandOtherCurrentLiabilities	0.20
	podd	Percentage Of Accounts Payable Accrued Expensesand Other Current Liabilities PercentageOfAccountsPayableAccruedExpensesandOtherCurrentLiabilities	0.16
CY2018Q2	podd	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized Per Offering Period ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedPerOfferingPeriod	800	shares
CY2017	podd	Tax Cuts And Jobs Act Of2017 Transition Tax For Accumulated Foreign Earnings Tax Expense Increase Decrease In Valuation Allowance TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsTaxExpenseIncreaseDecreaseInValuationAllowance	-800000	USD
CY2017	podd	Tax Cuts And Jobs Act Of2017 Transition Tax For Accumulated Foreign Earnings Tax Expense Reduction In Net Operating Loss TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsTaxExpenseReductionInNetOperatingLoss	-800000	USD
CY2017Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	59256000	USD
CY2018Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	48580000	USD
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	24413000	USD
CY2018Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	25191000	USD
CY2017Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	3542000	USD
CY2018Q2	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	3651000	USD
CY2017Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	55914000	USD
CY2018Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	52895000	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	53373000	USD
CY2018Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	49676000	USD
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	59256000	USD
CY2018Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	48580000	USD
CY2017Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	9273000	USD
CY2018Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	8512000	USD
CY2017Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	34942000	USD
CY2018Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	21470000	USD
	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P3Y09M15D
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	866206000	USD
CY2018Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	876641000	USD
CY2017Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7531000	USD
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	51600000	USD
CY2018Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	57900000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-493000	USD
CY2018Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2386000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	14655000	USD
CY2018Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6937000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	15117000	USD
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2541000	USD
CY2018Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	3219000	USD
CY2017Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3572000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	7077000	USD
CY2018Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	6616000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	13138000	USD
CY2017Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	500000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	990000	USD
CY2018Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	648000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1289000	USD
CY2017Q2	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	4072000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	8067000	USD
CY2018Q2	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	7264000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	14427000	USD
CY2017Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	300000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	600000	USD
CY2018Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	400000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	800000	USD
CY2017Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11914219	shares
CY2018Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	14344331	shares
CY2017Q4	us-gaap	Assets Assets	816744000	USD
CY2018Q2	us-gaap	Assets Assets	838856000	USD
CY2018Q1	us-gaap	Assets Assets	840004000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	537171000	USD
CY2018Q2	us-gaap	Assets Current AssetsCurrent	421793000	USD
CY2018Q1	us-gaap	Assets Current AssetsCurrent	547105000	USD
CY2017Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	167479000	USD
CY2018Q2	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	163546000	USD
CY2017	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	12300000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	4000000	USD
CY2018Q2	us-gaap	Capitalized Contract Cost Accumulated Amortization CapitalizedContractCostAccumulatedAmortization	3300000	USD
CY2018Q2	us-gaap	Capitalized Contract Cost Accumulated Impairment CapitalizedContractCostAccumulatedImpairment	0	USD
CY2018Q2	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	22100000	USD
CY2017Q4	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	0	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	7959000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	477000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	232000	USD
CY2018Q2	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	6554000	USD
CY2017Q4	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	0	USD
CY2018Q2	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	15475000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	272577000	USD
CY2018Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	136246000	USD
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	137174000	USD
CY2017Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	73488000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	272577000	USD
CY2018Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	136246000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-63686000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-136331000	USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2018Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2018Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	58319348	shares
CY2018Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	58975395	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	58319348	shares
CY2018Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	58975395	shares
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	58000	USD
CY2018Q2	us-gaap	Common Stock Value CommonStockValue	59000	USD
CY2017Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7638000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-17547000	USD
CY2018Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2541000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10153000	USD
	us-gaap	Contract With Customer Asset Reclassified To Receivable ContractWithCustomerAssetReclassifiedToReceivable	5100000	USD
CY2017Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2356000	USD
CY2018Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2338000	USD
CY2018Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4981000	USD
CY2018Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1100000	USD
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	2400000	USD
CY2018Q2	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	0	USD
	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	0	USD
CY2017Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	45117000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	87432000	USD
CY2018Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	42190000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	89953000	USD
CY2017Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	170448000	USD
CY2018Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	157152000	USD
CY2018Q2	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	150	Security
CY2017Q4	us-gaap	Deferred Costs And Other Assets DeferredCostsAndOtherAssets	1969000	USD
CY2018Q2	us-gaap	Deferred Costs And Other Assets DeferredCostsAndOtherAssets	17961000	USD
CY2017Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	14543000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1662000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4823000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	257000	USD
CY2018Q2	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	13229000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	6707000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7131000	USD
CY2018Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	53854000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	5329000	USD
CY2018Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	6044000	USD
CY2018Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1651000	USD
CY2018Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	942000	USD
CY2018Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	683000	USD
CY2018Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	979000	USD
CY2018Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1322000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	9680000	USD
CY2018Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	11791000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4351000	USD
CY2018Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	5747000	USD
CY2017Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	20493000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	39604000	USD
CY2018Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	23724000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	47494000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	39840000	USD
CY2018Q2	us-gaap	Goodwill Goodwill	39731000	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2017Q2	us-gaap	Gross Profit GrossProfit	64639000	USD
	us-gaap	Gross Profit GrossProfit	124037000	USD
CY2018Q2	us-gaap	Gross Profit GrossProfit	82072000	USD
	us-gaap	Gross Profit GrossProfit	157887000	USD
CY2017Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-7666000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-17547000	USD
CY2018Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1279000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-7515000	USD
CY2017Q2	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.13
	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.31
CY2018Q2	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.03
	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.14
CY2017Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	100000	USD
CY2017Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	101000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	200000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	197000	USD
CY2018Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	400000	USD
CY2018Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	412000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	700000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	745000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	44000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-2626000	USD
CY2017Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	4796000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	9803000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1527000	USD
CY2018Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	7290000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	15208000	USD
CY2017Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	7729000	USD
CY2018Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	27437000	USD
CY2017Q4	us-gaap	Inventory Net InventoryNet	33793000	USD
CY2018Q2	us-gaap	Inventory Net InventoryNet	40808000	USD
CY2018Q1	us-gaap	Inventory Net InventoryNet	33040000	USD
CY2017Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	2146000	USD
CY2018Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	5243000	USD
CY2017Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	23918000	USD
CY2018Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	8128000	USD
CY2017Q2	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	700000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1400000	USD
CY2018Q2	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	900000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1700000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	658228000	USD
CY2018Q2	us-gaap	Liabilities Liabilities	659708000	USD
CY2018Q1	us-gaap	Liabilities Liabilities	661124000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	816744000	USD
CY2018Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	838856000	USD
CY2018Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	840004000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	86025000	USD
CY2018Q2	us-gaap	Liabilities Current LiabilitiesCurrent	76109000	USD
CY2018Q1	us-gaap	Liabilities Current LiabilitiesCurrent	88650000	USD
CY2017Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	566173000	USD
CY2018Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	577119000	USD
CY2017Q4	us-gaap	Long Term Investments LongTermInvestments	125549000	USD
CY2018Q2	us-gaap	Long Term Investments LongTermInvestments	156060000	USD
CY2015Q2	us-gaap	Loss Contingency Claims Dismissed Number LossContingencyClaimsDismissedNumber	2	LegalMatter
CY2015Q2	us-gaap	Loss Contingency New Claims Filed Number LossContingencyNewClaimsFiledNumber	3	LegalMatter
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4194000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-8172000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-64266000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-117103000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3871000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10395000	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	-7767000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-17744000	USD
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	-1691000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-8260000	USD
CY2017Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4308000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-8881000	USD
CY2018Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5604000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-11840000	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2017Q2	us-gaap	Operating Expenses OperatingExpenses	67997000	USD
	us-gaap	Operating Expenses OperatingExpenses	132703000	USD
CY2018Q2	us-gaap	Operating Expenses OperatingExpenses	77747000	USD
	us-gaap	Operating Expenses OperatingExpenses	153562000	USD
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-3358000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8666000	USD
CY2018Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	4325000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	4325000	USD
CY2018Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	11910000	USD
CY2018Q2	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	3035000	USD
CY2018Q2	us-gaap	Operating Leases Future Minimum Payments Due In Rolling Year Four OperatingLeasesFutureMinimumPaymentsDueInRollingYearFour	2131000	USD
CY2018Q2	us-gaap	Operating Leases Future Minimum Payments Due In Rolling Year Three OperatingLeasesFutureMinimumPaymentsDueInRollingYearThree	2402000	USD
CY2018Q2	us-gaap	Operating Leases Future Minimum Payments Due In Rolling Year Two OperatingLeasesFutureMinimumPaymentsDueInRollingYearTwo	2651000	USD
CY2018Q2	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	0	USD
CY2018Q2	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	1691000	USD
CY2017Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	11499000	USD
CY2018Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	14947000	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1969000	USD
CY2018Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2486000	USD
CY2018Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	15295000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	186000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	264000	USD
CY2018Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-741000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-1059000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	129000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	197000	USD
CY2018Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-850000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1893000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-57000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-67000	USD
CY2018Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-109000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-834000	USD
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	6030000	USD
CY2018Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	6480000	USD
CY2018Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	6301000	USD
CY2017Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	488000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	922000	USD
CY2018Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1686000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3368000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	374000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-130000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	800000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	3428000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	12691000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	93383000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	117940000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	39068000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	89937000	USD
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2018Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2018Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2017Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9949000	USD
CY2018Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	17559000	USD
CY2018Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	15517000	USD
CY2017Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	9949000	USD
CY2018Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	11005000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	7891000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	11206000	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	68185000	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	90774000	USD
CY2016Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	4388000	USD
CY2017Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	4562000	USD
CY2017Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	4817000	USD
CY2017Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	5337000	USD
CY2018Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	5386000	USD
CY2018Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	5503000	USD
CY2017Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1653000	USD
CY2018Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	2335000	USD
CY2017Q4	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	3684000	USD
CY2018Q2	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	3168000	USD
CY2017Q2	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	880000	USD
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	1212000	USD
CY2018Q2	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	1412000	USD
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	3335000	USD
CY2017Q2	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	1135000	USD
	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	1641000	USD
CY2018Q2	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	1529000	USD
	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	3501000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	107864000	USD
CY2018Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	197564000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	722000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1586000	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	6687000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	269000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	0	USD
CY2017Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	18029000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	35529000	USD
CY2018Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	18418000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	38330000	USD
CY2017Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	500000	USD
CY2018Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	2000000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-707255000	USD
CY2018Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-695166000	USD
CY2018Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-686906000	USD
CY2017Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	109756000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	211469000	USD
CY2018Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	124262000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	247840000	USD
CY2017Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	29475000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	57570000	USD
CY2018Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	35605000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	67738000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	14655000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	15117000	USD
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2007167	shares
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	34.29
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	5400000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	17024000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	17000000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	129733	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	269853	shares
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	150872000	USD
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3377220	shares
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3199238	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	35.10
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	38.59
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	146303000	USD
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	3066211	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	32.91
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	40.28
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	76.32
CY2018Q2	us-gaap	Share Price SharePrice	85.70
CY2018Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	103188000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y8M
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y3M
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	318102	shares
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	9733	shares
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	158516000	USD
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	179148000	USD
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	178880000	USD
CY2017Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	0	USD
CY2018Q2	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	13958000	USD
CY2018Q1	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	5119000	USD
CY2018Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2017Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	57977000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	57836000	shares
CY2018Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	58833000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	58659000	shares
	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nature of the Business </font></div><div style="line-height:120%;padding-top:12px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Insulet Corporation (the "Company") is primarily engaged in the development, manufacturing and sale of its proprietary Omnipod Insulin Management System (the “Omnipod System”), an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. There are two</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font><font style="font-family:inherit;font-size:10pt;">primary types of insulin therapy practiced today: multiple daily injection (“MDI”) therapy using syringes or insulin pens; and pump therapy using insulin pumps. Insulin pumps are used to perform continuous subcutaneous insulin infusion, or insulin pump therapy, and typically use a programmable device and an infusion set to administer insulin into the person’s body. Insulin pump therapy has been shown to provide people with insulin-dependent diabetes with numerous advantages relative to MDI therapy. The Company estimates that approximately one-third of the Type 1 diabetes population in the United States use insulin pump therapy, and that less than 10% of the Type 2 diabetes population in the United States who are insulin-dependent use insulin pump therapy.</font><font style="font-family:inherit;font-size:10pt;color:#ff0000;"> </font><font style="font-family:inherit;font-size:10pt;">The Omnipod System features a small, lightweight, self-adhesive disposable tubeless Omnipod device, which is worn on the body for approximately three days at a time, and its wireless companion, the handheld Personal Diabetes Manager ("PDM"). The Omnipod System, which features two discreet, easy-to-use devices that communicate wirelessly and provide for virtually pain-free automated cannula insertion and blood glucose meter integration, eliminates the need for traditional MDI therapy or the use of traditional pump and tubing. The Company believes that the Omnipod System’s unique proprietary design and features allow people with insulin-dependent diabetes to manage their diabetes with unprecedented freedom, comfort, convenience, and ease.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commercial sales of the Omnipod System began in the United States in 2005. The Company sells the Omnipod System in the United States through direct sales to customers or through its distribution partners. The Omnipod System is currently available in multiple countries in Europe, as well as in Canada and Israel. </font></div><div style="line-height:120%;padding-top:12px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">To lower manufacturing costs, increase supply redundancy, add capacity closer to its largest customer base and support growth, the Company is constructing a highly-automated manufacturing facility in Acton, Massachusetts, with planned production out of the facility beginning in early 2019. The facility will also serve as the Company's global headquarters.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">The Company assumed on July 1, 2018, all commercial activities (including, among other things, distribution, sales, marketing, training and support) of its Omnipod System across Europe following the expiration of its prior distribution agreement with Ypsomed Distribution AG ("Ypsomed" or the "European distributor") on June 30, 2018. The Company will be required to pay to the former European distributor a per unit fee for sales of the Company's Omnipod device over the twelve months following the expiration of the distribution agreement. The fee will be based on sales of the Omnipod device to identified customers (as that term is defined in the distribution agreement) of the former European distributor who had previously entered into an agreement with the former European distributor for the purchase of Omnipod devices. The Company expects to recognize a liability and an associated intangible asset for this fee as qualifying sales of its Omnipod device are made to these identified customers during the twelve-month period between July 1, 2018 and June 30, 2019. The intangible asset will be amortized over its estimated useful life.</font></div><div style="line-height:120%;padding-top:12px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition to using the Omnipod System for insulin delivery, the Company also partners with global pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across multiple therapeutic areas.</font></div></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates in Preparation of Financial Statements</font></div><div style="line-height:120%;padding-top:0px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions in the application of certain of its significant accounting policies that may materially affect the reported amounts of assets, liabilities, equity, revenue and expenses. Actual results may differ from those estimates. See Note 3 related to the Company's adoption of Accounting Standards Update No. 2014-09, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers, </font><font style="font-family:inherit;font-size:10pt;">for a discussion of judgments associated with the recognition of revenue and deferral of cost to obtain a contract. </font></div></div>

Files In Submission

Name	View Source	Status
0001145197-18-000011-index-headers.html	Edgar Link	pending
0001145197-18-000011-index.html	Edgar Link	pending
0001145197-18-000011.txt	Edgar Link	pending
0001145197-18-000011-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
podd-20180630.xml	Edgar Link	completed
podd-20180630.xsd	Edgar Link	pending
podd-20180630_cal.xml	Edgar Link	unprocessable
podd-20180630_def.xml	Edgar Link	unprocessable
podd-20180630_lab.xml	Edgar Link	unprocessable
podd-20180630_pre.xml	Edgar Link	unprocessable
podd-2018x06x30_10q.htm	Edgar Link	pending
podd-exx101_20180630x10q.htm	Edgar Link	pending
podd-exx311_20180630x10q.htm	Edgar Link	pending
podd-exx312_20180630x10q.htm	Edgar Link	pending
podd-exx321_20180630x10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PODD
INSULET CORP Stock $podd

2018 Q2 Form 10-Q Financial Statement

#000114519718000011 Filed on August 02, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PODD INSULET CORP Stock $podd

2018 Q2 Form 10-Q Financial Statement

#000114519718000011 Filed on August 02, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PODD
INSULET CORP Stock $podd